Table 2

Auxological characteristics of children with CAH according to clinical manifestation and gender

MalesFemales
SW (n=20)NSW (n=9)SW (n=12)NSW (n=12)
Results expressed as mean (SD).
Patients treated with triptorelin were excluded.
*In healthy children, bone age (G&P) at onset of puberty (10.7 years in females, 11.5 years in males) was approximately 1.5 years retarded.11
SW, salt wasting; NSW, non-salt wasting; HSDSba, height SDS for bone age.
Age at diagnosis (y)0.12 (0.11)4.9 (2.4)0.03 (0.05)3.1 (2.9)
Length/height at diagnosis (SDS)−0.85 (0.93)3.0 (0.9)−0.27 (0.97)0.2 (0.7)
Age at onset of puberty (y)11.8 (1.5)11.2 (1.5)10.6 (0.84)10.4 (1.3)
Height at onset of puberty (SDS)−0.50 (0.89)0.86 (0.58)−0.66 (0.75)−0.2 (0.94)
HSDSba at onset of puberty−1.07−1.13−1.16−1.17
Bone age at onset of puberty (G&P)*12.5 (1.5)13.6 (1.0)11.2 (1.1)11.5 (1.7)
Height gain during puberty (cm)21.1 (6.8)19.6 (7.7)22.4 (5.3)21.1 (9.1)
Final height SDS−1.63 (1.3)−1.2 (1.0)−0.85 (0.82)−0.78 (1.4)
Target height SDS−0.35 (0.87)0.31 (0.5)0.40 (0.56)0.18 (0.85)
SDS FH corrected for TH−1.27 (0.94)−1.51 (0.7)−1.25 (0.72)−0.96 (1.3)